RNU2-24P

Across TCGA pan-cancer cohorts, RNU2-24P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU2-24P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU2-24P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU2-24P expression acts as an unfavorable survival marker, although some lineages such as COAD and LAML show a favorable association.

THCA, LUSC, and COAD are the cancer types where RNU2-24P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.829	0.963	.002	72	view →
LUSC	DFS	Tertile	All	0.219	0.542	.001	48	view →
COAD	DFS	Tertile	II,III,IV	0.931	0.742	.014	12	view →
SKCM	OS	Tertile	II,III,IV	0.088	0.366	.009	12	view →
LAML	DFS	Quartile	All	0.809	0.413	.003	12	view →
ACC	OS	Tertile	All	0.243	0.665	.020	12	view →
CHOL	DFS	Tertile	All	0.089	0.465	.036	9	view →
GBM	DFS	Tertile	All	0.132	0.303	.015	9	view →
PAAD	OS	Tertile	II,III,IV	0.404	0.579	.030	9	view →
ESCA	OS	Tertile	IV	0.238	0.713	.024	6	view →
LIHC	OS	Tertile	III,IV	0.877	0.602	.020	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU2-24P–THCA (OS)

Open the THCA breakdown →